Related Experiment Videos
Immune mechanisms in chronic inflammatory demyelinating neuropathy
Bernd C Kieseier1, Marinos C Dalakas, Hans-Peter Hartung
1Department of Neurology, Heinrich-Heine-Universität, Düsseldorf, Germany.
Neurology
|December 25, 2002
Summary
Chronic inflammatory demyelinating polyneuropathy (CIDP) is an immune-mediated peripheral neuropathy. This review details the immune mechanisms involved in CIDP pathogenesis, including T cells and antibodies, and discusses therapy considerations.
Area of Science:
- Neuroimmunology
- Peripheral Neuropathy Research
Background:
- Chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired, immune-mediated peripheral neuropathy.
- Understanding CIDP's etiology and immunopathogenesis has advanced with immunology principles.
- Current data on cellular and humoral factors remain insufficient for a unified hypothesis.
Purpose of the Study:
- To review current knowledge on immune mechanisms in CIDP pathogenesis.
- To discuss the roles of specific immune components in CIDP.
- To highlight the significance of axonal loss in CIDP therapy.
Main Methods:
- Literature review of fundamental immune mechanisms in CIDP.
- Synthesis of data on cellular and humoral factors.
- Discussion of T cells, macrophages, cytokines, co-stimulatory molecules, and anti-myelin antibodies.
Main Results:
- Identified key immune players in CIDP pathogenesis, including T cells, macrophages, and antibodies.
- Highlighted the fragmentary nature of current data, necessitating further research.
- Emphasized the role of concomitant axonal loss in CIDP therapy.
Conclusions:
- Immune mechanisms involving T cells, macrophages, cytokines, and antibodies are central to CIDP.
- Further research is needed to unify the understanding of CIDP immunopathogenesis.
- Therapeutic strategies must address both demyelination and secondary axonal loss in CIDP.